What a moment for the world — and for science. On Wednesday, the Pfizer/BioNTech vaccine was approved by the UK medicines regulator, making it the first coronavirus vaccine to be approved for mass use in any country after large-scale clinical trials. The vaccine is also one of the most effective, protecting 95 per cent of recipients from disease. There is light on the horizon amid the pandemic’s winter gloom.
對全世界——還有科學來說，這是一個多麼激動人心的時刻。週三，輝瑞(Pfizer)和BioNTech聯合研製的新冠疫苗獲得了英國藥品監管機構的批准，成爲首款在大規模臨牀試驗後在一個國家獲准向大眾提供的新冠疫苗。該疫苗也是最有效的疫苗之一，可以保護95%的接種者。在這個大流行肆虐的冬季，陰霾的天空終於出現了曙光。
您已閱讀11%（569字），剩餘89%（4603字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。